Effects of fluticasone furoate, vilanterol and umeclidinium bromide on moderate or severer asthmatic patients
Not Applicable
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000047506
- Lead Sponsor
- International University of Health and Welfare
- Brief Summary
Inhaled drugs were switched to FF/UMEC/VI 200/62.5/25 microgram for asthma patients. Peripheral and small airways were found to be dilated.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 114
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects who did not agree with the participation of the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ung function tests and/or asthma control tests
- Secondary Outcome Measures
Name Time Method